2-naphthol has been researched along with Dermatitis, Atopic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crumrine, D; Elias, PM; Feingold, KR; Fujiwara, S; Hatano, Y; Katagiri, K | 1 |
Ahrens, C; Grether-Beck, S; Grewe, M; Kapp, A; Karmann, K; Klotz, LO; Krutmann, J; Morita, A; Ruzicka, T; Sies, H; Stege, H; Werfel, T | 1 |
2 other study(ies) available for 2-naphthol and Dermatitis, Atopic
Article | Year |
---|---|
Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.
Topics: Adjuvants, Immunologic; Animals; Clobetasol; Dermatitis, Atopic; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Epidermis; Female; Glucocorticoids; Haptens; Mice; Mice, Hairless; Naphthols; Oxazolone; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Secondary Prevention; Triazines | 2011 |
Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy.
Topics: Antibodies, Blocking; Apoptosis; Dermatitis, Atopic; Deuterium; Fas Ligand Protein; fas Receptor; Humans; Ligands; Membrane Glycoproteins; Naphthols; Oxygen; Singlet Oxygen; Sodium Azide; T-Lymphocytes, Helper-Inducer; Ultraviolet Therapy | 1997 |